Pathogenesis of Prediabetes: Role of the Liver in Isolated Fasting Hyperglycemia and Combined Fasting and Postprandial Hyperglycemia
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
CONTEXT: People with prediabetes are at high risk of developing diabetes. OBJECTIVE: The objective of this study was to determine the pathogenesis of fasting and postprandial hyperglycemia in prediabetes. DESIGN: Glucose production, gluconeogenesis, glycogenolysis, and glucose disappearance were measured before and during a hyperinsulinemic clamp using [6,6-(2)H2]glucose and the deuterated water method corrected for transaldolase exchange. SETTING: The study was conducted at the Mayo Clinic Clinical Research Unit. PARTICIPANTS: Subjects with impaired fasting glucose (IFG)/normal glucose tolerance (NGT) (n = 14), IFG/impaired glucose tolerance (IGT) (n = 18), and normal fasting glucose (NFG)/NGT (n = 16) were studied. INTERVENTION: A hyperinsulinemic clamp was used. OUTCOME MEASURES: Glucose production, glucose disappearance, gluconeogenesis, and glycogenolysis were measured. RESULTS: Fasting glucose production was higher (P < .0001) in subjects with IFG/NGT than in those with NFG/NGT because of increased rates of gluconeogenesis (P = .003). On the other hand, insulin-induced suppression of glucose production, gluconeogenesis, glycogenolysis, and stimulation of glucose disappearance all were normal. Although fasting glucose production also was increased (P = .0002) in subjects with IFG/IGT, insulin-induced suppression of glucose production, gluconeogenesis, and glycogenolysis and stimulation of glucose disappearance were impaired (P = .005). CONCLUSIONS: Fasting hyperglycemia is due to excessive glucose production in people with either IFG/NGT or IFG/IGT. Both insulin action and postprandial glucose concentrations are normal in IFG/NGT but abnormal in IFG/IGT. This finding suggests that hepatic and extrahepatic insulin resistance causes or exacerbates postprandial glucose intolerance in IFG/IGT. Elevated gluconeogenesis in the fasting state in IFG/NGT and impaired insulin-induced suppression of both gluconeogenesis and glycogenolysis in IFG/IGT suggest that alteration in the regulation of these pathways occurs early in the evolution of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whilst it is firmly established that pathological pancreatic function and peripheral tissue insulin resistance are central to T2D aetiology/pathogenesis, there is increasing evidence that other extrapancreatic pathologies may contribute.30,191,192”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, research evidence over the last few decades suggests that some of these pathologies manifest during the prediabetic phase and is possibly therefore involved in both the disease pathogenesis and aetiology.191,192”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
The cited source says what the claim attributes to it.
In the citing paper
“Whilst it is firmly established that pathological pancreatic function and peripheral tissue insulin resistance are central to T2D aetiology/pathogenesis, there is increasing evidence that other extrapancreatic pathologies may contribute.30,191,192”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
In the citing paper
“For example, skin and liver pathology can manifest during the prediabetic stage, and even in individuals with metabolic syndrome before islet beta-cell dysfunction occurs.191,196”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
In the citing paper
“Interestingly, insulin-induced suppression of gluconeogenesis and glycogenolysis has also been shown to be impaired in individuals with prediabetes, suggesting that altered liver function is an important component during the initial stages of T2D pathology.191”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Dose-response characteristics for effects of insulin on production and utilization of glucose in man
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.6.e630 · Cited by 703
Self-citationThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413
Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M. R., Tuomi, T., & Groop, L. C. (2000) · Diabetes · doi:10.2337/diabetes.49.6.975 · Cited by 361
Meigs, J. B., Muller, D. C., Nathan, D. M., Blake, D. R., & Andres, R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1475 · Cited by 338
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Meyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care · doi:10.2337/dc06-0438 · Cited by 308
Weyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2197 · Cited by 292
Hanefeld, M., Koehler, C., Fuecker, K., Henkel, E., Schaper, F., & Temelkova-Kurktschiev, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.868 · Cited by 238
Bock, G., Dalla Man, C., Campioni, M., Chittilapilly, E., Basu, R., Toffolo, G., Cobelli, C., & Rizza, R. (2006) · Diabetes · doi:10.2337/db06-0319 · Cited by 230
Self-citation
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Satapati, S., Kucejova, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K., Fu, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82204 · Cited by 399
Cichosz, S. L., Kronborg, T., Laugesen, E., Hangaard, S., Fleischer, J., Hansen, T. K., Jensen, M. H., Poulsen, P. L., & Vestergaard, P. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0226 · Cited by 223
Brannick, B., Wynn, A., & Dagogo-Jack, S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216654227 · Cited by 177
Alkhalidy, H., Moore, W., Wang, A., Luo, J., McMillan, R. P., Wang, Y., Wei, Z. C., Hulver, M. W., & Liu, D. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.014 · Cited by 156
Miller, D. M., McCauley, K. F., & Dunham‐Snary, K. J. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70132 · Cited by 153
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 139
Edwards, C., & Cusi, K. J. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.007 · Cited by 120
Antihyperglycemic Action of Sinapic Acid in Diabetic Rats
Cherng, Y., Tsai, C.-C., Chung, H.-H., Lai, Y.-W., Kuo, S., & Cheng, J. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf403092b · Cited by 116
Decreased expression of hepatic glucokinase in type 2 diabetes
Haeusler, R. A., Camastra, S., Astiarraga, B., Nannipieri, M., Anselmino, M., & Ferrannini, E. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.12.007 · Cited by 111
Excessive Gluconeogenesis Causes the Hepatic Insulin Resistance Paradox and Its Sequelae
Onyango, A. N. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12294 · Cited by 93
Malin, S. K., Haus, J. M., Solomon, T. P. J., Blaszczak, A., Kashyap, S. R., & Kirwan, J. P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00441.2013 · Cited by 89
Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review
Chung, S. T., Chacko, S. K., Sunehag, A. L., & Haymond, M. W. (2015) · Diabetes · doi:10.2337/db15-0640 · Cited by 88
Glucose and Lipid Dysmetabolism in a Rat Model of Prediabetes Induced by a High-Sucrose Diet
Burgeiro, A., Cerqueira, M., Varela-Rodríguez, B. M., Nunes, S., Neto, P., Pereira, F. C., Reis, F., & Carvalho, E. (2017) · Nutrients · doi:10.3390/nu9060638 · Cited by 81
Kaur, K., Vig, S., Srivastava, R., Mishra, A., Singh, V. P., Srivastava, R., & Datta, M. (2015) · Diabetes · doi:10.2337/db14-1924 · Cited by 80
Malik, S. A., Acharya, J. D., Mehendale, N., Kamat, S. S., & Ghaskadbi, S. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1635252 · Cited by 79
Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes
Chung, S. T., Hsia, D. S., Chacko, S. K., Rodríguez, L. M., & Haymond, M. W. (2014) · Diabetologia · doi:10.1007/s00125-014-3455-x · Cited by 75
Type 2 diabetes: one disease, many pathways
Ha, J., & Sherman, A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2019 · Cited by 70
Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial
Napoli, N., Pannacciulli, N., Vittinghoff, E., Crittenden, D., Yun, J., Wang, A., Wagman, R., & Schwartz, A. V. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2991 · Cited by 63
Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
Kalra, S., Unnikrishnan, A., Baruah, M. P., Sahay, R. K., & Bantwal, G. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286888 · Cited by 63
Type 2 Diabetes: One Disease, Many Pathways
Ha, J., & Sherman, A. (2019) · doi:10.1101/648816 · Cited by 63
Altındağ, F., Rağbetli, M. Ç., Özdek, U., Koyun, N., Alhalboosi, J. K. I., & Elasan, S. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112443 · Cited by 60
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Satapati, S., Kucejová, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K. A., Fu, X., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86695 · Cited by 60
Takeno, K., Tamura, Y., Kawaguchi, M., Kakehi, S., Watanabe, T., Funayama, T., Furukawa, Y., Kaga, H., Yamamoto, R., Kim, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1650 · Cited by 58
Goyal, N., Sivadas, A., Vellarikkal, S. K., Jayarajan, R., Verma, A., Sivasubbu, S., Scaria, V., & Datta, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-08281-7 · Cited by 58
Moin, A. S. M., Dhawan, S., Cory, M., Butler, P. C., Rizza, R. A., & Butler, A. E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2496 · Cited by 56
Self-citationDynamic assessment of insulin secretion and insulin resistance in Asians with prediabetes
Magkos, F., Lee, M. H., Lim, M., Cook, A. R., Chhay, V., Loh, T. P., Chia, K. S., Baig, S., Ang, I. Y. H., Tay, J., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154957 · Cited by 53
Abegg, K., Bernasconi, L., Hutter, M., Whiting, L., Pietra, C., Giuliano, C., Lutz, T. A., & Riediger, T. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13020 · Cited by 49
Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes
Sharma, R., & Tiwari, S. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i5.556 · Cited by 46
Dwibedi, C. K., Axelsson, A. S., Abrahamsson, B., Fahey, J. W., Asplund, O., Hansson, O., Ahlqvist, E., Tremaroli, V., Bäckhed, F., & Rosengren, A. H. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01932-w · Cited by 41
Wang, Y., Wang, A., Alkhalidy, H., Luo, J., Moomaw, E., Neilson, A. P., & Liu, D. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900978 · Cited by 41
Ho, C.-H., Yu, H.-J., Wang, C.-Y., Jaw, F.-S., Hsieh, J.-T., Liao, W.-C., Pu, Y.-S., & Liu, S.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074173 · Cited by 40
“However, elevations in fasting and postprandial glucose levels may be caused by different mechanisms and may represent distinct stages of diabetes development [11,24-27].”
BackgroundGluconeogenesis and risk for fasting hyperglycemia in Black and White women
Chung, S. T., Courville, A. B., Onuzuruike, A. U., Cruz, M. G. L., Mabundo, L. S., DuBose, C. W., Kasturi, K., Cai, H., Gharib, A. M., Walter, P. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121495 · Cited by 40
Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study
Roncero‐Ramos, I., Alcala-Diaz, J. F., Rangel-Zúñiga, O. A., Gómez-Delgado, F., Jiménez-Lucena, R., García‐Ríos, A., Vals‐Delgado, C., Romero-Baldonado, C., Luque, R. M., Ordovás, J. M., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.027 · Cited by 39
Cathepsin S inhibition lowers blood glucose levels in mice
Lafarge, J.-C., Pini, M., Pelloux, V., Orasanu, G., Hartmann, G. R., Venteclef, N., Sulpice, T., Shi, G., Clément, K., & Guerre-Millo, M. (2014) · Diabetologia · doi:10.1007/s00125-014-3280-2 · Cited by 36
Prpa, E. J., Corpe, C. P., Atkinson, B., Blackstone, B., Leftley, E. S., Parekh, P., Philo, M. R., Kroon, P. A., & Hall, W. L. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108466 · Cited by 33
Tripathy, D., Merovci, A., Basu, R., Abdul-Ghani, M. A., & DeFronzo, R. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02304 · Cited by 31
Self-citationGlycaemia and hand grip strength in aging people: Guangzhou biobank cohort study
Liang, X., Jiang, C. Q., Zhang, W. S., Zhu, F., Jin, Y. L., Cheng, K. K., Lam, T. H., & Xu, L. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01808-0 · Cited by 31
Sharma, R., Kumari, M., Prakash, P., Gupta, S. K., & Tiwari, S. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00507.2019 · Cited by 30
The MST3/STK24 kinase mediates impaired fasting blood glucose after a high-fat diet
Iglesias, C., Floridia, E., Sartages, M., Porteiro, B., Fraile, M., Guerrero, A., Santos, D., Cuñarro, J., Tovar, S. A., Nogueiras, R., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4433-x · Cited by 28
Prediabetes Phenotype Influences Improvements in Glucose Homeostasis with Resistance Training
Eikenberg, J. D., Savla, J., Marinik, E. L., Davy, K. P., Pownall, J., Baugh, M. E., Flack, K. D., Boshra, S., Winett, R. A., & Davy, B. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148009 · Cited by 26
Mallad, A., Hinshaw, L., Man, C. D., Cobelli, C., Basu, R., Lingineni, R. K., Carter, R. E., Kudva, Y. C., & Basu, A. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0011 · Cited by 26
Self-citationAoyama‐Sasabe, S., Fukushima, M., Xin, X., Taniguchi, A., Nakai, Y., Mitsui, R., Takahashi, Y., Tsuji, H., Yabe, D., Yasuda, K., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1298601 · Cited by 26
Jing, S., Xiaoying, D., Xu, Y., Liu, R., Mingyu, G., Chen, Y., Yin, Y., Yufan, W., Sun, H., & Yongde, P. (2014) · Clinical Endocrinology · doi:10.1111/cen.12384 · Cited by 25
Takeno, K., Tamura, Y., Kakehi, S., Kaga, H., Kawamori, R., & Watada, H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab324 · Cited by 25
Burman, B. E., Bacchetti, P., Ayala, C. E., Gelman, N. O., Melgar, J., & Khalili, M. (2014) · Liver International · doi:10.1111/liv.12676 · Cited by 23
The Natural Course of Impaired Fasting Glucose
Święcicka-Klama, A., Połtyn–Zaradna, K., Szuba, A., & Zatońska, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_571 · Cited by 23
Huang, H. M., Lorenz, B. R., Zelmanovitz, P. H., & Chan, C. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010421 · Cited by 23
Kim, C., Kim, H., Kim, E., Bae, S., Choe, J., & Park, J. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.09.010 · Cited by 21
Glucose kinetics: an update and novel insights into its regulation by glucagon and GLP-1
Gastaldelli, A., Gaggini, M., & DeFronzo, R. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000384 · Cited by 19
NADPH Oxidase 3: Beyond the Inner Ear
Herb, M. (2024) · Antioxidants · doi:10.3390/antiox13020219 · Cited by 19
Decreased basal hepatic glucose uptake in impaired fasting glucose
Alatrach, M., Agyin, C., Adams, J. M., DeFronzo, R. A., & Abdul-Ghani, M. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4252-0 · Cited by 19
Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG
Alatrach, M., Agyin, C., Mehta, R. J., Adams, J. M., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01866 · Cited by 18
Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans
Varghese, R. T., Man, C. D., Sharma, A. R., Viegas, I., Barosa, C., Marques, C., Shah, M., Miles, J. M., Rizza, R. A., Jones, J. G., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1998 · Cited by 17
Self-citationBurhop, M., Schuchardt, J. P., Nebl, J., Müller, M., Lichtinghagen, R., & Hahn, A. (2022) · Nutrients · doi:10.3390/nu14020396 · Cited by 17
Insulin Management for Gestational and Type 2 Diabetes in Pregnancy
Valent, A. M., & Barbour, L. A. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005640 · Cited by 16
Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis
Ryuge, A., Kosugi, T., Maeda, K., Banno, R., Gou, Y., Zaitsu, K., Ito, T., Sato, Y., Hirayama, A., Tsubota, S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.142464 · Cited by 16
Funayama, T., Tamura, Y., Takeno, K., Kawaguchi, M., Kakehi, S., Watanabe, T., Furukawa, Y., Kaga, H., Yamamoto, R., Kanazawa, A., et al. (2017) · Scientific Reports · doi:10.1038/srep40277 · Cited by 16
Metformin use in prediabetes: is earlier intervention better?
Warrilow, A., Somerset, S. M., Pumpa, K. L., & Fleet, R. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01559-9 · Cited by 15
Cersósimo, E., Alatrach, M., Solis‐Herrera, C., Baskoy, G., Adams, J. M., HANSIS-DIARTE, A. A., Gastaldelli, A., Chávez, A. O., Triplitt, C. L., & DeFronzo, R. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad438 · Cited by 14
Heterogeneity of Gestational Diabetes and Risk for Adverse Pregnancy Outcome: A Cohort Study
Gong, Y., Wang, Q., Chen, S., Liu, Y., Li, C., Kang, R., Wang, J., Wei, T., Wang, Q., Li, X., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae754 · Cited by 13
Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus
Huang, J., Ou, H., Karnchanasorn, R., Samoa, R. A., Chuang, L., Chiu, K. C., & Feng, W. (2014) · Endocrine · doi:10.1007/s12020-014-0301-3 · Cited by 13
Sex Dependent Dysregulation of Hepatic Glucose Production in Lean Type 2 Diabetic Rats
Blesson, C. S., Schutt, A. K., Chacko, S. K., Marini, J. C., Mathew, P. R., Tanchico, D., Balakrishnan, M. P., & Yallampalli, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00538 · Cited by 13
Yang, J., Bi, Y., Liang, S., Gu, Z., Cheng, L., Li, C., Li, Z., Zhang, Y., & Hong, Y. (2020) · Food & Function · doi:10.1039/d0fo02494e · Cited by 13
Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes
Sanni, O., & Terre’Blanche, G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09668-8 · Cited by 13
Postprandial Glucose: A Variable in Continuum
Joshi, S., Kesavadev, J., M., P. K. K., Saboo, B., Mehta, A., Bhattacharyya, A., Sosale, A., Jabbar, P. K., Santosh, R., Deshmukh, V. C., et al. (2025) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514251370507 · Cited by 12
Insulin function in obese children within the low and high ranges of impaired fasting glycemia
Hagman, E., Ek, A. E., & Marcus, C. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12804 · Cited by 12
Du, W., Wang, F., Zhao, M., Zhang, H., Zhang, X., Zhao, J., & Gao, L. (2019) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2019.1656106 · Cited by 12
Kabeer, S. W., Sharma, S., Sriramdasu, S., & Tikoo, K. (2024) · Biological Research · doi:10.1186/s40659-024-00495-0 · Cited by 11
Alatrach, M., Agyin, C., Solis‐Herrera, C., Lavryneko, O., Adams, J. M., Gastaldelli, A., Triplitt, C. L., DeFronzo, R. A., & Cersósimo, E. (2022) · Diabetes Care · doi:10.2337/dc21-1798 · Cited by 11
Kazeminasab, F., Baharlooie, M., Rezazadeh, H., Soltani, N., & Rosenkranz, S. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114340 · Cited by 10
Liu, X., Janzen, C., Zhu, Y., Seamans, M. J., Fei, Z., Nianogo, R. A., & Chen, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111576 · Cited by 10
Milk-derived bioactive peptides in insulin resistance and type 2 diabetes
Ramezan, M., Arzhang, P., & Shin, A. C. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109849 · Cited by 10
Hannon, T. S., Kirkman, M. S., Patel, Y. R., Considine, R. V., & Mather, K. J. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2553 · Cited by 10
Non-catalytic mechanisms of KMT5C regulating hepatic gluconeogenesis
Zhao, Q., Cui, X., Zhu, Q., Li, F., Bao, R., Shi, T., Liu, H., Lv, W., Xu, Y., Gao, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56696-y · Cited by 9
Kadowaki, S., Tamura, Y., Sugimoto, D., Kaga, H., Suzuki, R., Someya, Y., Yamasaki, N., Sato, M., Kakehi, S., Kanazawa, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124084 · Cited by 9
Effects of transaldolase exchange on estimates of gluconeogenesis in type 2 diabetes
Rajpal, A., Dube, S., Carvalho, F., Simões, A. R., Figueiredo, A., Basu, A., Jones, J. G., & Basu, R. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00245.2013 · Cited by 8
Self-citationAdenosine A1 receptor is dispensable for hepatocyte glucose metabolism and insulin sensitivity
Jain, S., Barella, L. F., Wess, J., Reitman, M. L., & Jacobson, K. A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114739 · Cited by 8
Basu, A., YADAV, Y. R., Carter, R. E., & Basu, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa241 · Cited by 8
Self-citationHagen, I. V., Helland, A., Bratlie, M., Midttun, Ø., McCann, A., Ulvik, A., Mellgren, G., Ueland, P. M., & Gudbrandsen, O. A. (2023) · BMC Nutrition · doi:10.1186/s40795-022-00661-1 · Cited by 7
Díaz‐Rizzolo, D. A., Yao, H., Santos‐Báez, L. S., Popp, C. J., Borhan, R., Sordi‐Guth, A., DeBonis, D., Manoogian, E. N. C., Panda, S., Cheng, B., et al. (2025) · Nutrients · doi:10.3390/nu17122026 · Cited by 7
Kim, H.-L., Jung, Y., Kim, H. I., Sung, N., Kim, M.-J., Han, I.-J., Kim, G., Nho, E. Y., Park, S.-Y., Han, Y., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080405 · Cited by 6
Phytochemical analysis and antihyperglycemic activity of Castilleja arvensis
Díaz-Román, M. A., Acevedo‐Fernández, J. J., Ávila-Villarreal, G. M., Negrete‐León, E., & Aguilar‐Guadarrama, A. B. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.105839 · Cited by 6
Omobolanle, A. F., Iyedupe, M. O., Oluwatosin, A., Kalejaiye, N. O., Lydia, A. A., & Adekunle, A. L. (2023) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410177 · Cited by 5
Silveira, A. C., Oliveira, P. F., Alves, M. G., Rato, L., & Silva, B. M. (2024) · PharmaNutrition · doi:10.1016/j.phanu.2024.100393 · Cited by 5
Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5
Trace glucose fluxes in individuals with prediabetes using stable isotopes
Du, S., Xia, F., Xu, X., Zhang, H., Zhu, C., & Lu, Y. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140001 · Cited by 5
van Stee, M. F., Krishnan, S., Groen, A. K., & de Graaf, A. A. (2019) · BMC Biomedical Engineering · doi:10.1186/s42490-019-0030-z · Cited by 5
Hagman, E. (2016) · Figshare · Cited by 5
Lo, C., Lee, J., Tsai, W.-T., Huang, C., Yang, Y., Lii, C., & Chen, H. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109981 · Cited by 4
Ezugwu, U. M., Onyenekwe, C. C., Ukibe, N. R., Ahaneku, J., & Obeagu, E. I. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i47b33120 · Cited by 4
Bahadoran, Z., Kashani, Z., Mahdavi, M., Mirmiran, P., & Azizi, F. (2025) · European journal of medical research · doi:10.1186/s40001-025-02337-5 · Cited by 4
Alaei-Shahmiri, F., Soares, M. J., Lahouti, M., Zhao, Y., & Sherriff, J. L. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00508-1 · Cited by 4
Leohr, J. K., & Kjellsson, M. C. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2604 · Cited by 4
Small molecule kaempferol, a novel regulator of glucose homeostasis in diabetes
Moore, W. T. (2017) · VTechWorks (Virginia Tech) · Cited by 4
Ho, C., Yu, H., Wang, C., Jaw, F., Hsieh, J., Liao, W.-C., Pu, Y., & Liu, S. (2013) · PLoS ONE · doi:10.1371/annotation/c226aa64-8d3b-4c29-971b-84f87b618291 · Cited by 4
HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes
Li, H., Zhang, X., Liang, X., Li, S., Cui, Z., Zhao, X., Wang, K., Zha, B., Ma, H., Xu, M., et al. (2025) · eLife · doi:10.7554/elife.103663.3 · Cited by 3
Kerlikowsky, F., Bartsch, M., Jonas, W., Hahn, A., & Schuchardt, J. P. (2025) · Marine Drugs · doi:10.3390/md23040139 · Cited by 3
Metabolic perturbations of post-load hyperglycemia vs. fasting hyperglycemia
Lu, J., Peng, J., Ma, X., Zhang, Y., Zhu, W. M., He, X., Ying, L., Bao, Y., Zhou, J., & Jia, W. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0018-6 · Cited by 3
HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetesPreprint
Li, H., Zhang, X., Liang, X., Li, S., Cui, Z., Zhao, X., Wang, K., Zha, B., Ma, H., Xu, M., et al. (2025) · eLife · doi:10.7554/elife.103663 · Cited by 3
Metadata
- Authors
- Basu, R., Barosa, C., Jones, J., Dube, S., Carter, R., Basu, A., & Rizza, R. A.
- Affiliations
- Endocrine Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition (R.B., S.D., A.B., R.A.R.), Rochester, Minnesota 55905
- University of Coimbra (PT)
- Mayo Clinic (US)
- Corresponding author
- Basu, Rita
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-03-01
- Volume
- 98
- Issue
- 3
- Pages
- E409-E417
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3590488
- OpenAlex
- W2029696243
- Cited by
- 121
- References
- 25
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 12 · 2023: 7 · 2022: 5 · 2021: 12 · 2020: 13 · 2019: 8 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 8
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health (UL1TR000135)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029953, P30DK050456, DK50456, DK 29953, R37DK029953)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, fasting hyperglycemia, postprandial hyperglycemia, hepatic glucose production, gluconeogenesis, glycogenolysis, glucose disappearance, insulin resistance, impaired fasting glucose, impaired glucose tolerance, hyperinsulinemic-euglycemic clamp, type 2 diabetes pathogenesis, liver
- MeSH terms
- Adult, Aged, Blood Glucose, C-Peptide, Carbon Isotopes, Diabetes Mellitus, Type 2, Fasting, Female, Glucagon, Gluconeogenesis, Humans, Hyperglycemia, Hyperinsulinism, Insulin, Liver, Male, Middle Aged, Prediabetic State, Glucose Clamp Technique, Glucose Intolerance, Glycogenolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.